Goiter screening

	Goiter Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Goiter from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Goiter screening On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Goiter screening All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Goiter screening
CDC on Goiter screening
Goiter screening in the news
Blogs on Goiter screening
Directions to Hospitals Treating Cushing’s disease
Risk calculators and risk factors for Goiter screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Screening for Goiter initially involves physical examination followed by blood tests for free T4 and TSH and finally thyroid scan, ultrasound and biopsy to rule out malignanacy.

Screening

Screening for Goiter includes the following approaches and progresses to the next approach based on the result of earlier screening procedure: ^[1] ^[2] ^[3] ^[4]
- Physical exam:
  - Involves the assessment of the size and the extent of enlargement of the thyroid gland. If the enlargement is positive, blood tests for Free T4 and TSH are evaluated.
- Blood Tests:
  - Blood tests are carried out in order to determine whether the Goiter is affecting the production of thyroid hormone.
    - Free thyoxine (T4)
    - Thyroid stimulating hormone (TSH)
- Further evaluation to rule out malignancy:
  - Based on the results of the physical exam and blood tests, further evaluation involving the following is advised in order to rule out malignant transformation of the gland:
    - Thyroid scan
    - Ultrasound
    - Biopsy of the gland

References

↑ Ladenson PW (1996). "Optimal laboratory testing for diagnosis and monitoring of thyroid nodules, goiter, and thyroid cancer". Clin. Chem. 42 (1): 183–7. PMID 8565224.
↑ Dietlein M, Moka D, Schmidt M, Theissen P, Schicha H (2003). "[Prevention, screening and therapy of thyroid diseases and their cost-effectiveness]". Nuklearmedizin (in German). 42 (5): 181–9. PMID 14571314.
↑ Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID doi.org/10.1148/radiology.173.2.2678263 Check |pmid= value (help).
↑ Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID doi.org/10.1148/radiology.181.3.1947082 Check |pmid= value (help).

Template:WH Template:WS

[pmid8565224-1] Ladenson PW (1996). "Optimal laboratory testing for diagnosis and monitoring of thyroid nodules, goiter, and thyroid cancer". Clin. Chem. 42 (1): 183–7. PMID 8565224.

[pmid14571314-2] Dietlein M, Moka D, Schmidt M, Theissen P, Schicha H (2003). "[Prevention, screening and therapy of thyroid diseases and their cost-effectiveness]". Nuklearmedizin (in German). 42 (5): 181–9. PMID 14571314.

[pmiddoi.org/10.1148/radiology.173.2.2678263-3] Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID doi.org/10.1148/radiology.173.2.2678263 Check |pmid= value (help).

[pmiddoi.org/10.1148/radiology.181.3.1947082-4] Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID doi.org/10.1148/radiology.181.3.1947082 Check |pmid= value (help).

[1]

[2]

[3]

[4]

Goiter screening

Overview

Screening

References

Navigation menu